Sablich Kim 4
4 · Jazz Pharmaceuticals plc · Filed Mar 10, 2023
Insider Transaction Report
Form 4
Sablich Kim
EVP, GM of U.S.
Transactions
- Sale
Ordinary Shares
[F1][F2]2023-03-08$139.42/sh−1,752$244,264→ 31,821 total - Sale
Ordinary Shares
[F1][F3]2023-03-08$140.19/sh−1,261$176,780→ 30,560 total
Footnotes (3)
- [F1]This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
- [F2]Reflects the sale of ordinary shares executed in multiple transactions at prices ranging from $138.95 to $139.94. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
- [F3]Reflects the sale of ordinary shares executed in multiple transactions at prices ranging from $139.97 to $140.30. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
Signature
By: Adam Guttman, as attorney in fact For: Kimbely Sablich|2023-03-10